Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma

NCT00003909 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Untreated Childhood Brain Stem Glioma

Interventions

DRUG: motexafin gadolinium
RADIATION: radiation therapy
OTHER: pharmacological study

Sponsor

National Cancer Institute (NCI)